MedPath

Tolerability of the Immersive Virtual Reality System Grail in Subjects Affected by Rett Syndrome

Not Applicable
Completed
Conditions
Rett Syndrome
Interventions
Device: GRAIL
Registration Number
NCT05691582
Lead Sponsor
IRCCS Eugenio Medea
Brief Summary

The main goal of this study is to investigate the tolerability to the use of the GRAIL system in subjects affected by Rett syndrome, particularly referred to:

1. Grail environment (training in dark conditions, interaction with wide and surrounding screen, positioning over the treadmill);

2. time to prepare a set of body marker in order to execute a gait analysis;

3. walking activity over treadmill, with immersive virtual reality;

4. proprioceptive stimulatione provided by the GRAIL platform;

5. cognitive-attentive span time to the activity proposed. The secondary goal is to understand if a training that avail of treadmill and virtual reality would be useful in the future in improving gait characteristics in subjects affected by Rett syndrome

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
9
Inclusion Criteria
  • subjects affected by Rett Syndrome that are able to walk with hands support (corresponding to a score ranging from 1 to 3 in item 8 of Rett Syndrome Gross Motor Scale)
Exclusion Criteria
  • subjects unable to walk and with a complete incapacity to undestand verbal directions

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Single armGRAILAll the subjects recruited have 4 access to GRAIL, in 4 different day, to test their tolerability to the proposals
Primary Outcome Measures
NameTimeMethod
Total score on the Suitability Evaluation Questionnaire (SEQ)immediately after the treatment

it is a subjective questionnaire assessing the suitability of the intervention. This is not a health outcome. Indeed SEQ is a questionnaire designed for virtual reality, composed by 13 questions, with a response graded on a 5-point Likert Scale, and a last open question.

It measures measures enjoyment, sense of being in the system, feeling of success and control, realism, easy-to-understand instructions and general discomfort; furthermore it is aimed to detect issues frequently associated with virtual rehabilitation systems, like dizziness or nausea symptoms, eye discomfort, disorientation or confusion symptoms and sense of progress in rehabilitation. Finally, it evaluates the perceived difficulty of the task and the observed difficulty related with the physical interface used in the system.

Secondary Outcome Measures
NameTimeMethod
Happiness indeximmediately after the treatment

The parameter comes from a taxonomy based on the analysis of the communication of subjects with profound intellectual disabilities. it consists of 12 categories, and each can receive the score "1" when present or "0" when absent

Gait analysis spatial parameters: temporal parameters in seconds and kinematics in degreesimmediately after the treatment

The gait analysis assessment is conducted over the GRAIL (Gait Real-time Analysis Interactive Lab) system .

It is a laboratory suitable for motion analysis and VR-based rehabilitation. It is composed by a treadmill, provided with two belts that can be driven at different speeds and it is equipped with integrated force platforms. An immersive semicircular screen is placed in front of the treadmill, where VR environments, synchronized with the treadmill movement, are projected. The system uses a Vi-con motion capture system and 3 video cameras to perform motion detection and gait analysis: accordingly, 25 markers were placed on specific anatomical landmarks of the body. Each participant performed a ten-minute familiarization phase and then about 40 steps were acquired.

Spatiotemporal parameters, such as walking velocity, stance duration, stride length and step width, and kinematic parameters of pelvis, hip, knee and ankle were computed.

Trial Locations

Locations (1)

IRCCS E. Medea

🇮🇹

Bosisio Parini, Lecco, Italy

© Copyright 2025. All Rights Reserved by MedPath